Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
about
The CB2 receptor and its role as a regulator of inflammationSystematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation.2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.Role of cannabinoid receptors in the control of gastrointestinal motility and perception.Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids.Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach.Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.Mast cell-neural interactions contribute to pain and itch.A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.
P2860
Q28066700-22AD5337-2977-481A-8B5A-89FB18A8C7E0Q34454367-448A4487-CD0F-4FA2-85A0-6960E1AB8030Q34471868-7EA03EC0-892F-4F27-B512-5C48908047F6Q36726650-DCDE726E-4EBB-4236-A4D3-B00016956FDAQ37143569-DDF6B996-7B79-4C3F-8945-FC97D6040FA8Q37198046-C275015C-2E2F-4785-B020-555BD6D085E3Q37216210-6DBA2D73-1D3B-43F1-A80C-EE1F9F6D682AQ37244823-B54F08B9-CC51-4D76-B0F7-D19162937ABEQ37345943-2FDEFF8C-16BA-49A6-966C-19885DB92654Q37601380-C7183CBC-91A5-4F26-A831-4AA73B69504FQ38615088-5967348F-08D8-4E24-A2E7-49A4CD7E31E1Q40122119-006D739D-7C76-435A-9FCB-C87BA82EDF48Q46480886-FA8F8139-F2B9-466C-A73C-504ABFB6FAD8Q47343398-077C86F7-3DC8-44ED-9916-E2BCD5005A7BQ50068940-33D0D7BA-A10B-459D-B7CC-F7A93167DD5FQ55048045-AA5C8D53-229D-46D2-8F40-EE0037D782E2
P2860
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
@en
type
label
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
@en
prefLabel
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
@en
P2093
P2860
P356
P1433
P1476
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
@en
P2093
Andrea L Small-Howard
Chaker N Adra
Helen Turner
Lori M N Shimoda
P2860
P304
P356
10.1042/BJ20041682
P407
P577
2005-06-01T00:00:00Z